# The Letrozole Administration During Luteal Phase

> **NCT02686151** · PHASE3 · UNKNOWN · sponsor: **The Affiliated Hospital of Inner Mongolia Medical University** · enrollment: 50 (estimated)

## Conditions studied

- Ovarian Hyperstimulation Syndrome

## Interventions

- **DRUG:** Letrozole
- **DRUG:** Polygeline
- **DRUG:** Sodium Chloride
- **DRUG:** dexamethasone

## Key facts

- **NCT ID:** NCT02686151
- **Lead sponsor:** The Affiliated Hospital of Inner Mongolia Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12
- **Primary completion:** 2024-03
- **Final completion:** 2024-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02686151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02686151, "The Letrozole Administration During Luteal Phase". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02686151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*